Medical Weight Loss for Hicksville, New York Residents

Hicksville, New York residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Hicksville through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Hicksville: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in New York. Results vary. Doctor review just $119 (medication separate).

Why Hicksville Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Hicksville is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across New York trust us to guide a serious decision about their health.

If you are searching for medical weight loss in Hicksville, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

Patients in Hicksville get the identical physician-supervised treatment that someone walking into our Costa Mesa office would get, all of it handled by telehealth so New York residents never have to travel. We care for patients throughout Hicksville and the greater Nassau County area of central Long Island. There is no distance surcharge for living outside Costa Mesa, and we accept HSA, FSA, Klarna, and Affirm to make starting easier across New York.

Tirzepatide from $233 per month and semaglutide from $166 per month cost the same whether you are in downtown Hicksville or a rural corner of New York. Compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and for Hicksville patients it starts at $166 per month, billed separately. New York is among the most populous states in the nation, and New Hope Weight Loss serves patients across it, from the city to upstate, by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Hicksville patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Hicksville

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Hicksville home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Hicksville

Is New Hope Weight Loss available to Hicksville without a local branch?

Yes, even though we have no branch in Hicksville. Our one physical clinic is in Costa Mesa, California, and we reach Hicksville, New York through telehealth. A secure video consult with Dr. Anjmun Sharma is where your medical history is reviewed and your fit for a compounded GLP-1 plan is confirmed.

From Hicksville, can I avoid traveling for appointments?

You can skip travel entirely. The program is built around telehealth, so Hicksville patients meet the doctor online, complete intake digitally, and stay connected by message. If approved, medication ships to your Hicksville home in cold-pack packaging that maintains a safe temperature on the way.

What will Hicksville patients spend on the program?

Expect $119 for the physician visit. Compounded semaglutide is offered from $166 per month or $499 for 90 days, and tirzepatide from $233 per month. The medication is billed separately. HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge for Hicksville residents at all.

What areas of Hicksville do you serve?

We serve patients from across Hicksville by telehealth, including Hicksville and the greater Nassau County area of central Long Island.

Who qualifies for the program in Hicksville?

Eligibility for Hicksville patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Hicksville Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Hicksville, New York by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.